Core Viewpoints - The non-bank financial industry is experiencing a positive trend in its fundamentals due to deepening capital market reforms, with a projected 30% profit growth over the next 25 years [5][10] - The average daily trading volume in the Shanghai and Shenzhen markets is 21.1 trillion CNY, reflecting a 4.5% decrease week-on-week [5] - The net profit of 150 securities companies is expected to reach 219.439 billion CNY in 2025, representing a year-on-year increase of 31.2% [5] Group 1: Industry Performance - As of March 28, 2026, the Shanghai Composite Index is at 3913.72 points, down 1.09%, while the Shenzhen Component Index is at 13760.37, down 0.76% [10] - The non-bank financial sector indices have seen declines of 3.55% and 5.72% for securities and insurance, respectively [10] Group 2: Insurance Sector Insights - The insurance sector's annual reports show a slowdown in growth due to changes in the market environment in Q4, but the long-term trend remains positive [16] - The net profit growth for insurance companies is expected to be in double digits for the year, despite a high base in 2024 [16] - Key stocks to watch in the insurance sector include China Pacific Insurance, Ping An Insurance, and China Life Insurance [16] Group 3: Securities Sector Developments - The introduction of a "light asset, high R&D" recognition standard has been expanded to the main board, enhancing the inclusivity of the capital market [17][18] - The new standards aim to improve the flexibility of refinancing rules and guide funds towards key technology sectors [18] - The adjustments to the standards include raising the R&D investment ratio for the ChiNext board from 3% to 5%, reinforcing the board's positioning [21] Group 4: Investment Recommendations - The report suggests focusing on companies with strong quarterly performance catalysts, including CITIC Securities, Huatai Securities, and China Merchants Securities [5] - In the insurance sector, recommended stocks include China Taiping, New China Life, and AIA Group [16] - For Hong Kong stocks, quality dividend stocks such as China Shipbuilding Leasing and Hong Kong Exchanges are highlighted [5]

Investment Rating - The report maintains a "Recommend" rating for the company, with a target price of 49.6 RMB for 2026 [2][9]. Core Insights - In 2025, the company achieved a net profit attributable to shareholders of 154.08 billion RMB, representing a year-on-year increase of 44.1%. The new business value reached 45.75 billion RMB, up 35.7% year-on-year. The intrinsic value at the end of 2025 was 1.47 trillion RMB, a growth of 4.8% [2][9]. - The total investment return rate for 2025 was 6.09%, an increase of 0.59 percentage points compared to the previous year. The company plans to distribute a cash dividend of 0.856 RMB per share (before tax) for the year [2][9]. Financial Summary - **Revenue and Profit Forecasts**: - 2025 Revenue: 615.68 billion RMB, with a growth rate of 16.5% - 2025 Net Profit: 154.08 billion RMB, with a growth rate of 44.1% - Earnings per Share (EPS) for 2025: 5.45 RMB [4][10] - **Valuation Ratios**: - Price-to-Earnings (P/E) Ratio for 2025: 7.2 - Price-to-Book (P/B) Ratio for 2025: 1.9 [4][10] - **Market Performance**: - The company’s stock price fluctuated between 51.03 RMB and 34.83 RMB over the past 12 months [6]. Business Performance - The company’s total premium income for 2025 was 729.89 billion RMB, reflecting an 8.7% year-on-year increase. The new single premium income grew by 9.3% year-on-year, while the first-year regular premium income decreased by 2.4% [9]. - The company’s investment assets reached 7.42 trillion RMB by the end of 2025, a 12.3% increase year-on-year, with equity investments rising significantly [9]. Strategic Outlook - The report suggests that the company is actively increasing its equity allocation to amplify market gains, which is expected to drive high growth in performance. The expansion of bank insurance outlets is anticipated to support new business growth, while the transformation of individual insurance products is showing significant results [9].

Investment Rating - The report maintains a "BUY" rating for China Life, with a target price (TP) raised to HK$33 from the previous HK$31, implying a potential upside of 31.8% from the current price of HK$25.04 [3][10]. Core Insights - China Life reported a net profit of RMB154 billion for FY25, representing a 44.1% year-over-year increase, despite a net loss of RMB13.7 billion in 4Q25 due to fair value losses amid volatile market conditions [10][12]. - The company's net asset value increased by 16.8% year-over-year to RMB595.2 billion, with a return on equity (ROE) of 27.8%, up 6.2 percentage points from the previous year [10][12]. - The dividend per share (DPS) rose by 31.7% year-over-year to RMB0.86, exceeding expectations and indicating a payout ratio of 15.7% [10][12]. - Value of new business (VNB) surged by 35.7% year-over-year to RMB45.8 billion, driven by growth in both agency and bancassurance channels [10][12]. - Total investment assets grew by 12.3% year-over-year to RMB7.42 trillion, with a notable increase in the mix of stocks and equity funds [10][12]. Financial Performance Summary - For FY25, insurance revenue was RMB214.1 billion, a 2.9% increase from FY24, while insurance service expenses decreased by 17.6% to RMB148.7 billion [12][14]. - The net investment results for FY25 were RMB123.9 billion, a 31% increase year-over-year, although 4Q25 saw a negative result of RMB20.1 billion due to fair value contractions [10][12]. - The new business value margin (FYP basis) improved to 19.5% in FY25, with agency new business margin growing by 9.3 percentage points to 35% [10][12]. Share Performance and Market Data - The market capitalization of China Life is approximately HK$707.76 billion, with an average turnover of HK$2.13 billion over the last three months [4]. - The stock has experienced a 20.2% decline over the past month and a 12.0% decline over the past three months, but a 17.9% increase over the past six months [6].

Investment Rating - The report maintains a "Buy" rating for China Life Insurance [2][6] Core Views - China Life achieved simultaneous growth in scale, value, and efficiency in 2025, with total premiums exceeding 700 billion yuan, setting a new industry record [4][6] - The company demonstrated strong performance with a 16.5% year-over-year increase in operating revenue to 615.68 billion yuan and a 44.1% increase in net profit attributable to shareholders, reaching 154.08 billion yuan [4][6] - The company’s new business value (NBV) reached 45.75 billion yuan, a 35.7% year-over-year increase, indicating sustained leadership in value creation [4][6] Financial Performance - Total premiums for 2025 increased by 8.7% year-over-year to 729.89 billion yuan, with first-year premiums at 116.21 billion yuan, maintaining the industry lead [4][6] - The company’s weighted average ROE improved to 27.81%, up 6.22 percentage points year-over-year, reflecting enhanced profitability [4][6] - Investment assets reached 7.42 trillion yuan, with total investment income of 387.69 billion yuan, a 25.8% increase year-over-year [4][6] Business Structure and Channels - The company optimized its business structure, with life, annuity, and health insurance premiums accounting for 31.75%, 32.11%, and 31.23% respectively [4][6] - The individual insurance channel generated total premiums of 551.79 billion yuan, a 4.3% year-over-year increase, while the bancassurance channel saw a remarkable 45.5% increase in total premiums [4][6] - Internet insurance premiums grew by 38.9% year-over-year, indicating a solid multi-channel strategy [4][6] Future Projections - The report forecasts net profits for 2026, 2027, and 2028 to be 165.50 billion yuan, 176.69 billion yuan, and 189.24 billion yuan respectively, with year-over-year growth rates of 7.4%, 6.8%, and 7.1% [6][7] - Operating revenue is expected to grow to 651.45 billion yuan in 2026, reflecting a 5.8% increase year-over-year [7][9] Valuation Metrics - As of the end of 2025, the company’s total assets were 7.59 trillion yuan, with a return on equity (ROE) of 25.9% [5][12] - The price-to-earnings (PE) ratio is projected to decrease from 6.92 in 2025 to 5.64 by 2028, indicating potential undervaluation [11][12]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the market index [2][6]. Core Insights - The company achieved simultaneous growth in scale, value, and efficiency in 2025, with total premiums exceeding 700 billion yuan, marking a record in the industry. Revenue reached 615.68 billion yuan, a year-on-year increase of 16.5%, and net profit attributable to shareholders was 154.08 billion yuan, up 44.1% year-on-year [4][6]. - The company's new business value (NBV) reached 45.75 billion yuan, a 35.7% increase year-on-year, showcasing its strong value creation capabilities [4]. - The company has effectively optimized its business structure, with a balanced distribution of new premiums across life, annuity, and health insurance segments, each contributing approximately one-third to the total [4]. - The investment segment showed robust performance, with total investment assets reaching 7.42 trillion yuan, a 12.3% increase year-on-year, and total investment income of 387.69 billion yuan, up 25.8% year-on-year [4][6]. - The company has made significant strides in digital transformation, enhancing operational efficiency and customer experience through AI and digital services [4][6]. Financial Performance Summary - Total revenue for 2025 was 615.68 billion yuan, with a projected growth rate of 5.8% for 2026 [7]. - Net profit attributable to shareholders for 2025 was 154.08 billion yuan, with forecasts of 165.50 billion yuan for 2026, reflecting a year-on-year growth of 7.4% [7]. - The company's return on equity (ROE) for 2025 was 25.9%, with a projected decline to 24.0% by 2026 [12]. Asset and Liability Overview - As of December 31, 2025, total assets amounted to 7.59 trillion yuan, with total liabilities at 6.98 trillion yuan [11][13]. - The company's equity attributable to shareholders was 595.21 billion yuan, with projections of 688.88 billion yuan for 2026 [11][13].

Core Viewpoint - China Life Insurance reported a significant increase in net profit and total premium income for 2025, indicating strong financial performance and growth potential in the insurance sector [1]. Financial Performance - In 2025, China Life achieved a net profit of 1540.78 billion yuan, a year-on-year increase of 44.1% - Total premium income reached 7298.87 billion yuan, growing by 8.7% - By the end of 2025, total assets amounted to 7.59 trillion yuan, up 12.1%, while net assets increased to 6083.93 billion yuan, a rise of 16.7% [1]. Strategic Opportunities - The chairman highlighted the next five years as a golden strategic opportunity period, driven by economic, policy, demand, and technological dividends - The strategic goals include enhancing value creation capabilities, digital transformation, and risk management [2]. Investment Performance - Total investment income for 2025 was 3876.94 billion yuan, an increase of 794.43 billion yuan or 25.8% from the previous year - The investment return rate was 6.09%, marking a 59 basis points increase from 2024, the third highest since the company went public in 2007 [6]. - Equity investments were identified as a key driver for profit growth, with a strategic increase in equity allocation by nearly 5 percentage points [6][7]. Investment Strategy - The company focuses on three main areas for equity investments: core assets with stable cash flows, emerging industries through private equity funds, and innovative tools for industrial upgrades [8]. - Key sectors for investment include artificial intelligence, healthcare, and green energy, aligning with national strategic priorities [9]. Fixed Income Investments - As of the end of 2025, bond investments totaled 4.3 trillion yuan, accounting for 57.36% of total investment assets - The company plans to enhance fixed income strategies in a low-interest-rate environment, focusing on long-term quality assets [10]. International and Real Estate Investments - International investments represent less than 0.89% of total assets, indicating a cautious approach amid geopolitical uncertainties [11]. - Real estate investments decreased slightly, with a focus on core assets in major cities, maintaining quality and rental income [12].

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company reported a net profit attributable to shareholders of CNY 154.08 billion for 2025, representing a year-on-year increase of 44.1%. However, the Q4 net profit was a loss of CNY 13.73 billion, primarily due to adjustments in the capital market [2] - The company's embedded value reached CNY 1.47 trillion, up 4.8% year-on-year, while the new business value (NBV) was CNY 45.75 billion, reflecting a 35.7% increase [2] - The company plans to distribute a cash dividend of CNY 0.618 per share for the end of 2025, which, combined with the interim dividend, totals CNY 0.856 per share for the year, amounting to approximately CNY 24.2 billion, or 16% of the net profit [2] Summary by Sections New Business Value (NBV) - The company achieved a new business value of CNY 45.75 billion in 2025, a 35.7% increase year-on-year. The growth rates for Q1, H1, and Q1-3 were +4.8%, +20.3%, and +41.8% respectively. The new single premium was CNY 234.08 billion, up 9.3% year-on-year [3] - The individual insurance channel's NBV increased by 25.5% to CNY 39.30 billion, while other channels saw a 169.3% increase to CNY 6.45 billion, contributing 14% to the total NBV [3] Investment Performance - As of the end of the reporting period, the company's investment assets totaled CNY 7.42 trillion, a 12.3% increase from the beginning of the year. The total investment income was CNY 387.69 billion, a 25.8% increase year-on-year, while net investment income decreased by 1.0% to CNY 193.80 billion [4] - The total investment return rate reached 6.09%, an increase of 0.6 percentage points year-on-year [4] Financial Forecasts - The company maintains its forecasts for insurance service revenue at CNY 220.5 billion for 2026 and CNY 230.4 billion for 2027, with a new forecast of CNY 239.1 billion for 2028. The net profit forecasts are CNY 130.4 billion for 2026 and CNY 133.3 billion for 2027, with a new forecast of CNY 135.0 billion for 2028 [5] - The earnings per share (EPS) forecasts are CNY 4.61 for 2026, CNY 4.72 for 2027, and CNY 4.78 for 2028 [5]

Summary of Key Points from the Conference Call Company Overview - **Company**: China Life Insurance - **Industry**: Life Insurance Core Insights and Arguments 1. **2025 Performance Highlights**: - Achieved record high performance since 2018 with total investment return rate of 6.09%, up 25.8% year-on-year - Proposed dividend of 24.2 billion yuan, an increase of 32% year-on-year [2][13] - Individual insurance channel contributed 85% of new business value, with growth capability up 40% year-on-year [2] 2. **Investment Strategy**: - Increased equity investment ratio by nearly 5 percentage points, exceeding 1.2 trillion yuan, focusing on technology and high-dividend stocks [2] - Alternative investment scale exceeded 1 trillion yuan, with a strategic shift towards equity rather than value decline [2][6] - Focused on sectors like AI, semiconductors, health, and green energy through private equity funds, nurturing 22 listed companies with a total market value exceeding 1 trillion yuan [2][8] 3. **Reform Initiatives for 2026**: - Five key reform areas: digital transformation, management model upgrade, multi-channel development, customer management, and investment capability enhancement [4][5] - Emphasis on digital integration in product design, sales, and risk management to drive high-quality growth [5] 4. **Long-term Care Insurance and Health Insurance**: - Actively participating in long-term care insurance projects since 2016, with over 70 pilot projects [12] - Health insurance premium income exceeded 120 billion yuan in 2025, with plans for diversified product offerings and improved service integration [12] 5. **Market Position and Future Outlook**: - Aiming to become a world-class life insurance company by enhancing value creation capabilities and digital transformation [19] - Anticipating continued strong growth in 2026, with a focus on optimizing business structure and enhancing value creation [3][20] Additional Important Content 1. **Geopolitical Risks**: - Minimal impact from geopolitical risks due to low exposure in overseas investments (<0.89% of total assets) [10][11] - Monitoring global geopolitical developments and their potential effects on energy prices and inflation expectations [10] 2. **Investment Performance Drivers**: - Strong investment performance attributed to China's high-quality economic development and a stable capital market [8] - Strategic asset allocation adjustments to capture market opportunities, including increased allocation to high-dividend stocks [8] 3. **Dividend Policy**: - Committed to stable and improving dividend levels, with a total market value exceeding 1.1 trillion yuan, up 16% from the beginning of the year [14] 4. **Challenges in Individual Insurance Channel**: - Individual insurance channel showed slower growth in new single premiums, but remains a core channel contributing significantly to new business value [20] 5. **Real Estate Investment Trends**: - Investment in real estate remains below 2% of total investment assets, with a focus on core assets in major cities [17][18] This summary encapsulates the key points discussed in the conference call, highlighting the company's performance, strategic initiatives, and outlook for the future.

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][8] Core Views - The company's performance for 2025 met expectations, with a year-on-year increase in net profit attributable to shareholders of 44.1% to 154.1 billion yuan, although the growth rate decreased by 16.5 percentage points compared to the previous three quarters due to significant increases in the second half of 2025 and capital market fluctuations in the fourth quarter [5] - The company has increased its allocation to equity in the secondary market to 17%, with a total investment asset scale of 7.42 trillion yuan, reflecting a year-on-year growth of 12.3% [7] - The company has adjusted its profit forecast downwards due to increased capital market volatility and geopolitical risks, with expected net profits for 2026-2028 revised to 164.24 billion, 186.28 billion, and 222.85 billion yuan respectively [8] Financial Performance - The company's total revenue for 2025 was 615.68 billion yuan, with a year-on-year growth rate of 16.48% [9] - The net profit attributable to shareholders for 2025 was 154.08 billion yuan, with a year-on-year growth rate of 44.09% [9] - The company’s earnings per share for 2025 is projected to be 5.45 yuan, with a price-to-earnings ratio of 7.24 [9] Investment Analysis - The company has seen a significant increase in new business value (NBV), which rose by 35.7% year-on-year to 45.75 billion yuan, slightly above expectations [6] - The contribution from the bancassurance channel has been substantial, with a year-on-year increase of 169.3% in NBV to 6.45 billion yuan [10] - The company has maintained a dividend payout ratio of 15.7%, with an annual dividend of 0.856 yuan, reflecting a year-on-year increase of 31.7% [5]

Core Viewpoint - The article discusses the increasing attention and activity in the S fund market, highlighting China Life's significant investment in a new S fund as part of a broader trend of diversified exit strategies in the private equity sector [4][11]. Group 1: Investment Activities - China Life Insurance Company announced a commitment of 2.8 billion RMB to establish the Fujian Xinxin Rui Science and Technology Innovation Equity Investment Fund, with a total planned contribution of approximately 4.0154 billion RMB [8]. - In addition to the new S fund, China Life has made substantial investments earlier in the year, totaling 15.3 billion RMB across multiple private equity funds, including a 12.492 billion RMB investment in a Yangtze River Delta innovation fund and an 8.4915 billion RMB investment in a second phase of a pension industry fund [10]. Group 2: Market Trends - The S fund market has seen a significant increase in activity, with a report indicating that the total transaction volume in China's private equity secondary market reached approximately 92.3 billion RMB by Q3 2025, marking a 182% year-on-year increase [14]. - The number of transactions also surged, with 867 deals recorded, reflecting a 234% increase compared to the previous year, indicating a growing interest and participation in the S market [14]. - The article notes that government funds and financial institutions are the primary participants in the S market, driven by a deeper understanding of S transactions among various stakeholders [14]. Group 3: Future Outlook - The article suggests that the S fund is evolving from an emergency tool to a crucial component of exit strategies, with the potential for GP and LP to have more options as the market matures [19]. - The ongoing development of the S market is expected to lead to a more diversified and mature investment landscape, reflecting a shift in attitudes from resistance to proactive engagement with S funds [19].